Sacubitril/Valsartan for the Prevention and Treatment of Postinfarction Heart Failure: Ready to Use?

被引：1
|
作者：
Del Buono, Marco G. [1 ,2 ]
Damonte, Juan, I [1 ,3 ]
Trankle, Cory R. [1 ]
Bhardwaj, Hem [1 ]
Markley, Roshanak [1 ]
Turlington, Jeremy [1 ]
Van Tassell, Benjamin W. [1 ,4 ]
Salloum, Fadi N. [1 ]
Abbate, Antonio [1 ]
机构：
[1] Virginia Commonwealth Univ, Pauley Heart Ctr, Div Cardiol, Dept Internal Med, Richmond, VA 23298 USA
[2] Univ Cattolica Sacro Cuore, Dept Cardiovasc & Thorac Sci, Rome, Italy
[3] Hosp Italiano Buenos Aires, Dept Hemodynam & Intervent Cardiol, Buenos Aires, DF, Argentina
[4] Virginia Commonwealth Univ, Sch Pharm, Richmond, VA 23298 USA
来源：
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 2021年 / 78卷 / 03期
关键词：
ACUTE MYOCARDIAL-INFARCTION; CLINICAL-EVIDENCE; MORTALITY; MORBIDITY; SURVIVORS; RAMIPRIL;
D O I：
10.1097/FJC.0000000000001103
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：331 / 333
页数：3
相关论文
共 50 条
  • [31] Changing the treatment of heart failure with reduced ejection fraction: clinical use of sacubitril-valsartan combination
    Kaplinsky, Edgardo
    JOURNAL OF GERIATRIC CARDIOLOGY, 2016, 13 (11) : 914 - 923
  • [32] Optimal Usage of Sacubitril/Valsartan for the Treatment of Heart Failure: The Importance of Optimizing Heart Failure Care in Canada
    Huitema, Ashlay A.
    Daoust, Alexia
    Anderson, Kim
    Poon, Stephanie
    Virani, Sean
    White, Michel
    Rojas-Fernandez, Carlos
    Zieroth, Shelley
    McKelvie, Robert S.
    CJC OPEN, 2020, 2 (05) : 321 - 327
  • [33] Changing the treatment of heart failure with reduced ejection fraction:clinical use of sacubitril-valsartan combination
    Edgardo Kaplinsky
    Journal of Geriatric Cardiology, 2016, 13 (11) : 914 - 923
  • [34] Use of phenomapping to determine response of treatment by sacubitril/valsartan in patients with heart failure with reduced ejection fraction
    Godet, M.
    Raitiere, O.
    Chopra, H.
    Guignant, P.
    Fauvel, C.
    Gaudin, K.
    Eltchaninoff, H.
    Beuer, F.
    EUROPEAN HEART JOURNAL, 2019, 40 : 735 - 735
  • [35] The impact of the use of sacubitril/valsartan on clinical and echocardiographic parameters in heart failure patients
    Almaghraby, A. Abdallah
    Abdelnabi, M.
    Oz, T. Kemaloglu
    Elgowelly, M.
    Saleh, Y.
    Badran, H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 240 - 240
  • [36] SACUBITRIL/VALSARTAN VS ENALAPRIL USE IN HOSPITALIZED PATIENTS WITH HEART FAILURE IN SPAIN
    Parrondo Garcia, F. J.
    Garcia-Quintana, A.
    VALUE IN HEALTH, 2023, 26 (12) : S172 - S172
  • [37] Use of sacubitril/valsartan in patients with heart failure: evidence from the real world
    Valladales-Restrepo, Luis Fernando
    Sanchez-Ramirez, Nicolas
    Usma-Valencia, Andres Felipe
    Velasquez-Quirama, Santiago
    Henao-Martinez, Manuela
    Castro-Rodriguez, Jorge Alejandro
    Gaviria-Mendoza, Andres
    Machado-Duque, Manuel Enrique
    Machado-Alba, Jorge Enrique
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2211 - 2219
  • [38] Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy
    Gregorietti, Vanesa
    Lopez Fernandez, Teresa
    Costa, Diego
    Ortega Chahla, Elias
    Daniele, Andres J.
    CARDIO-ONCOLOGY, 2020, 6 (01)
  • [39] Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy
    Vanesa Gregorietti
    Teresa Lopez Fernandez
    Diego Costa
    Elías Ortega Chahla
    Andrés J. Daniele
    Cardio-Oncology, 6
  • [40] ANMCO position paper on the use of sacubitril/valsartan therapy in patients with heart failure
    Di Tano, Giuseppe
    Di Lenarda, Andrea
    Gabrielli, Domenico
    Aspromonte, Nadia
    De Maria, Renata
    Frigerio, Maria
    Iacoviello, Massimo
    Mortara, Andrea
    Murrone, Adriano
    Nardi, Federico
    Oliva, Fabrizio
    Pontremoli, Roberto
    Scherillo, Marino
    Senni, Michele
    Urbinati, Stefano
    Gulizia, Michele Massimo
    GIORNALE ITALIANO DI CARDIOLOGIA, 2018, 19 (10) : 568 - 590
12345